New drug combo tested for Tough-to-Treat blood cancer
NCT ID NCT04910568
Summary
This early-stage trial is testing a new drug called cevostamab, both by itself and in combination with other approved myeloma medications. It aims to find safe doses and see if these treatments can help control multiple myeloma that has returned or stopped responding to other therapies. The study involves 126 adults with relapsed or refractory disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O. Spedali Civili Di Brescia-P.O. Spedali Civili
Brescia, Lombardy, 25123, Italy
-
Asst Papa Giovanni Xxiii
Bergamo, Lombardy, 24127, Italy
-
CHU de Poitiers - La Miletrie
Poitiers, 86021, France
-
City of Hope
Duarte, California, 91010, United States
-
City of Hope - Lennar Foundation Cancer Center
Irvine, California, 92618, United States
-
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center
Denver, Colorado, 80218, United States
-
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
-
Fakultni Nemocnice Ostrava
Ostrava, 708 52, Czechia
-
Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2, Canada
-
Hospital General Universitario Gregorio Marañon
Madrid, 28009, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hôpital Saint-Louis
Paris, 75475, France
-
Karmanos Cancer Institute.
Detroit, Michigan, 48201, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3002, Australia
-
Pratia Onkologia Katowice
Katowice, 41-500, Poland
-
Rambam Medical Center
Haifa, 3109601, Israel
-
Rigshospitalet
København Ø, 2100, Denmark
-
Royal Marsden Hospital
Sutton, SW3 6JJ, United Kingdom
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
University College London Hospitals NHS Foundation Trust
London, W1T 7HA, United Kingdom
-
University Health Network
Toronto, Ontario, M5G 2M9, Canada
-
Uniwersytecki Szpital Kliniczny w Poznaniu
Późna, 60-569, Poland
-
Uniwersyteckie Centrum Kliniczne
Gda?sk, 80-214, Poland
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Yamagata University Hospital
Yamagata, 990-9585, Japan
Conditions
Explore the condition pages connected to this study.